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ABSTRACT 1 
Background: Antenatal influenza vaccination is an important public health intervention for 2 
preventing serious illness in mothers and newborns, yet uptake remains low. 3 
Aim: To evaluate trends in seasonal influenza vaccine coverage and identify determinants for 4 
vaccination among pregnant women in Western Australia. 5 
Methods: We conducted an annual telephone survey in a random sample of post-partum 6 
women who delivered a baby in Western Australia between 2012 and 2014. Women were 7 
asked whether influenza vaccination was recommended and/or received during their most 8 
recent pregnancy; women were also asked why or why they were not immunised. 9 
Findings: Between 2012 and 2014, influenza vaccine coverage increased from 22.9% to 10 
41.4%. Women who reported receiving the majority of their antenatal care from a private 11 
obstetrician were significantly more likely to have influenza vaccination recommended to them 12 
than those receiving the majority of their care from a public antenatal hospital or general 13 
practitioner (p<0.001). In 2014, the most common reason women reported for accepting 14 
influenza vaccination was to protect the baby (92.8%) and the most common reason for being 15 
unimmunised was lack of a healthcare provider recommendation (48.5%). 16 
Discussion: Antenatal influenza vaccination uptake is increasing, but coverage remains 17 
below 50%. A recommendation from the principal care provider is an important predictor of 18 
maternal influenza vaccination.  19 
Conclusion: Antenatal care providers, including midwives, have a key role in providing 20 
appropriate information and evidence-based recommendations to pregnant women to ensure 21 
they are making informed decisions. Consistent recommendations from antenatal care 22 
providers are critical to improving influenza vaccine coverage in pregnant women. 23 
 24 
Keywords: Influenza Vaccine; Pregnant Woman; Maternal Health; Maternal Vaccination; 25 
Antenatal Vaccination 26 
  27 
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SUMMARY OF RELEVANCE 28 
Problem 29 
Influenza vaccination during pregnancy prevents serious morbidity in mothers and their 30 
infants; however, uptake has been suboptimal historically. 31 
What is already known 32 
Previous studies have shown that 60% of pregnant women are recommended to receive 33 
seasonal influenza vaccine during their pregnancy, and as a result, one in three pregnant 34 
women receives an influenza vaccine each year. 35 
What this paper adds 36 
Uptake improved between 2012 and 2014. Advice from an antenatal care provider was the 37 
most important motivator for influenza vaccination in pregnant women, yet 40% of pregnant 38 
women were not recommended an influenza vaccine.  These results imply there is a greater 39 
role for antenatal care providers, including midwives, in encouraging antenatal vaccination 40 
and promoting the health of pregnant women and their newborns.  41 
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INTRODUCTION 42 
Antenatal influenza vaccination has been demonstrated to reduce morbidity in both mothers 43 
and their infants [1-3]. Infection with seasonal influenza during pregnancy is associated with 44 
severe illness and increased risk of hospitalisation and adverse infant outcomes, including 45 
small for gestational age and low birth weight births [4, 5]. Influenza vaccination during 46 
pregnancy has been shown to reduce the risk of these poor neonatal health outcomes [6, 7]. 47 
Despite the known benefits of maternal influenza vaccination, historically, fewer than 50% of 48 
pregnant women in Australia receive an influenza vaccine each year [8-10].  49 
 50 
Previous research has found that a recommendation by an antenatal care provider is the 51 
primary reason pregnant women get vaccinated against influenza, and lack of discussion with 52 
a provider remains a commonly cited reason for non-vaccination [11-13]. Protecting the infant 53 
from infection, perceiving influenza as a serious illness, and believing that the vaccine is safe 54 
and effective have also been identified as strong predictors of influenza vaccination during 55 
pregnancy [14-16]. Concerns about the safety of the vaccine for the developing fetus and 56 
potential side effects are other commonly cited reasons for non-vaccination among pregnant 57 
women [8, 11, 15, 16]. Because information on maternal influenza vaccination has generally 58 
been unavailable in Western Australia, the Western Australia Department of Health (WA 59 
Health) has conducted an annual survey in Western Australia since 2012.  60 
 61 
It was the goal of this study to use annual survey data to assess trends in uptake of trivalent 62 
influenza vaccine (TIV) in pregnant women between 2012 and 2014, as well as factors 63 
associated with vaccination and non-vaccination. 64 
 65 
METHODS 66 
Between 2012 and 2014, WA Health conducted an annual survey of mothers who had recently 67 
given birth to a live infant in Western Australia [8, 14]. A random sample of live births was 68 
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selected in November each year using the Western Australian Midwives Notification System, 69 
which is a legally mandated state-wide data collection of attended births in Western Australia 70 
[17]. The sample was randomly selected from all births using a random number generator. 71 
Sample size was determined based on the number of participants required to measure vaccine 72 
uptake with a precision of ±1.5%. In 2012, mothers residing in non-metropolitan areas were 73 
oversampled. In 2013, mothers from two metropolitan health services were oversampled; 74 
these oversampling techniques were not repeated in 2014. Selected women were invited to 75 
participate in a 10 minute telephone interview; women who declined the invitation were 76 
removed from the sample. The remaining women were telephoned by trained interviewers in 77 
December to March of each year.  78 
 79 
The interview included questions regarding whether the woman was advised by a healthcare 80 
provider (HCP) to be immunised against influenza, whether she had received TIV during her 81 
most recent pregnancy, and factors associated with vaccination status. The survey instrument 82 
is based on the Pregnancy Risk Assessment Monitoring Systems survey, which is a validated 83 
state-based telephone survey of pregnant women conducted by the United States Centers for 84 
Disease Control and Prevention [18]. This study was reviewed and approved by the Western 85 
Australia Department of Health Human Research Ethics Committee (Project 2014/67). 86 
 87 
Data collection 88 
Women were asked to self-report whether they were immunised against influenza during their 89 
most recent pregnancy. Where possible, immunisation providers were contacted to verify the 90 
self-reported vaccination status. Women were considered “vaccinated” if they self-reported a 91 
vaccination which was verified by their immunisation provider. For women who self-reported 92 
immunisations administered by a provider without immunisation records (i.e. private 93 
workplace, pharmacy), it was assumed the woman was “vaccinated.” Women who self-94 
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reported not being vaccinated and those who self-reported being vaccinated but their 95 
nominated provider indicated no such vaccination was given were considered “unvaccinated.” 96 
 97 
Vaccinated women were asked why they chose to be vaccinated, and unvaccinated women 98 
were asked why they were not vaccinated; reasons not listed on the survey were recorded 99 
verbatim and coded into themes.  100 
 101 
Demographic information was collected during the survey, including the woman’s age, 102 
postcode of residence, highest level of education completed, presence of chronic medical 103 
conditions, and the primary antenatal care provider for her most recent pregnancy (e.g., 104 
private obstetrician, general practitioner, public antenatal hospital clinic, private practice 105 
midwife, or other). The postcode of residence provided was used to determine whether the 106 
woman lived in a metropolitan or non-metropolitan area as well as the socioeconomic status 107 
of the woman, as determined by the Socio-Economic Indexes for Areas (SEIFA) score [19]. 108 
Women were assigned into tertiles of socioeconomic status based on these scores.  109 
http://www.slp.wa.gov.au/legislation/statutes.nsf/main_mrtitle_1563_homepage.html 110 
Data analysis 111 
To account for the oversampling strategies implemented in 2012 and 2013, annual survey 112 
results were weighted according to the known distribution of births in the state. The odds of 113 
receiving a recommendation for influenza vaccination and the odds of receiving an influenza 114 
vaccine during pregnancy were examined by age group, health status, educational attainment, 115 
socioeconomic status, area of residence and antenatal care provider using multivariate logistic 116 
regression analyses which controlled for each of the other variables. Multivariable logistic 117 
regression models were used to estimate influenza vaccination status by year, adjusting for 118 
area of residence, socioeconomic status, and educational attainment. Complete-case 119 
analyses were performed in SAS version 9.4 (SAS Institute Inc., Cary NC, USA).  120 
 121 
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RESULTS 122 
A total of 2,828 women (2012: n=566; 2013: n=1,114; 2014: n=1,148) were telephoned, of 123 
whom 2,018 (71.3%) completed the interview (2012: n=416; 2013: n=831; 2014: n=771). Of 124 
the 814 women who did not complete an interview, 43.0% could not be contacted after 10 125 
attempts, 41.5% had incorrect or disconnected telephone numbers, 7.2% declined 126 
participation, 6.8% were non-English speaking, and 1.5% were unavailable at the time of 127 
interview. One-half of respondents were between 30 and 45 years of age (53.6%), and two-128 
thirds of respondents had post-secondary school qualifications (67.8%); 40.8% were in the 129 
highest socioeconomic tertile. The majority of women resided in the metropolitan area (72.9%) 130 
and reported no chronic medical conditions (86.8%). 131 
 132 
A total of 783 (38.8%) women self-reported a vaccination during their pregnancy and 756 133 
(96.5%) of these women gave permission to verify the vaccination (Figure 1). Of these, 718 134 
(91.7%) were classified as vaccinated. Records could not be located by the immunisation 135 
provider for 65 (8.6%) women and these women were considered unvaccinated. A total of 136 
1,278 women included in the final analysis were classified as unvaccinated.  137 
 138 
Overall, between 2012 and 2014, 57.2% of women reported having been recommended TIV 139 
during their most recent pregnancy and 35.3% of women received the vaccine (Table 1). After 140 
adjusting for sociodemographic factors, women with chronic medical conditions were at higher 141 
odds of receiving a recommendation for TIV from their provider (AOR: 1.39; 95% CI: 1.01-142 
1.91), while those residing outside the metropolitan area were at lower odds of receiving this 143 
recommendation (AOR: 0.75; 95% CI: 0.58-0.98). Women who received the majority of care 144 
from a general practitioner or public antenatal hospital clinic had lower odds of receiving a 145 
recommendation for TIV as compared to women who received care from a private obstetrician 146 
(AOR: 0.73; 95% CI: 0.54-0.99; AOR: 0.76; 95% CI: 0.60-0.95, respectively). Women who 147 
received the majority of their care from a general practitioner or public antenatal hospital also 148 
Trends in antenatal influenza vaccine uptake, 7 
had lower odds of receiving TIV during pregnancy than women who received care from a 149 
private obstetrician (AOR: 0.70; 95% CI: 0.52-0.94 and OR: 0.60; 95% CI 0.48-0.76, 150 
respectively). Although not statistically significant, women who reported receiving the majority 151 
of their antenatal care from a private practice midwife had the lowest odds of receiving a 152 
recommendation (AOR: 0.49, 95% CI: 0.20-1.24) or receiving TIV during their pregnancy 153 
(AOR: 0.50, 95% CI: 0.17-1.43).  154 
 155 
Between 2012 and 2014, TIV coverage increased from 22.9% to 41.4% (p<0.001). Subgroup 156 
analyses indicated that during this period uptake increased for all groups of age, 157 
socioeconomic, education and residence; however, uptake did not significantly change in 158 
mothers with at least one chronic medical condition (p=0.38).  The majority of mothers were 159 
vaccinated in their second trimester (57.2%); one-third (29.1%) were vaccinated in the third 160 
trimester, and 13.7% were vaccinated in the first trimester. Most commonly, women were 161 
immunised by their general practitioner (2012: 70.3%, 2013: 60.3%, 2014: 63.1%).  162 
 163 
The proportion of women who reported having been recommended influenza vaccination 164 
during pregnancy increased from 37.2% in 2012 to 62.1% in 2014 (p<0.001) (Figure 2). The 165 
proportion of unvaccinated women who would have been vaccinated if it had been 166 
recommended by a HCP did not change throughout the study period, remaining between 75.2 167 
and 80.5% (p=0.63). In 2014, 65.7% of women would have been vaccinated had a midwife 168 
recommended the vaccine, 69.4% if a general practitioner had recommended the vaccine, 169 
and 72.2% if an obstetrician had recommended the vaccine to them during pregnancy (Figure 170 
2). 171 
 172 
Between 2012 and 2014, the reason women most commonly cited for receiving TIV was to 173 
protect the baby (89.7%), followed by receiving a recommendation from a HCP (82.5%). The 174 
proportion of women who were immunised during pregnancy in order to protect the baby 175 
increased from 74.7% in 2012 to 92.8% in 2014 (p=0.002), and the proportion immunised 176 
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because a provider recommended the vaccine increased from 78.8% in 2012 to 85.5% in 177 
2014, although not significantly (p=0.06) (Table 2). The proportion of unimmunised women 178 
who indicated they did not normally get an annual influenza vaccination decreased from 67.0% 179 
in 2012 to 39.7% in 2014 (p<0.001). The percentage of women who were not vaccinated 180 
because of concerns about potential harm to the baby decreased from 49.6% in 2012 to 42.9% 181 
in 2014, although this decrease was only borderline significant (p=0.05). However, the 182 
proportion of women who declined vaccination due to potential side effects to the mother did 183 
not significantly change between 2012 and 2014 (46.8% to 43.3%, p=0.22). 184 
 185 
DISCUSSION 186 
Using a state-wide survey of women who recently delivered a live baby in Western Australia, 187 
we estimated that, overall between 2012 and 2014, 57.2% of women were recommended an 188 
influenza vaccine during their pregnancy and 35.3% received a seasonal influenza vaccine. 189 
While there has been significant improvement since 2012, less than half of pregnant women 190 
currently receive an influenza vaccine during their pregnancy. These results identify a need 191 
for better promotion of influenza immunisation by antenatal care providers to their pregnant 192 
patients, particularly considering the known benefits of antenatal influenza vaccination. 193 
 194 
Pregnant women and young infants are at high risk of severe influenza infection and 195 
associated complications [4, 20, 21], and influenza immunisation during pregnancy has been 196 
shown to prevent 36% of respiratory illnesses in mothers and 63% of influenza cases in infants 197 
<6 months [2]. Based on the evidence supporting the benefits of seasonal influenza 198 
vaccination to mother and infant, the World Health Organisation considers pregnant women 199 
the highest priority group for seasonal influenza vaccination programs [22]. Results from our 200 
investigation highlight potential strategies for improving maternal influenza vaccine uptake. 201 
 202 
More than 40% of women were not recommended TIV during pregnancy, and nearly 50% of 203 
women who received their antenatal care from a general practitioner or at a public hospital 204 
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antenatal clinic, where midwives have extensive access to women in Western Australia, were 205 
not recommended TIV. These results suggest that general practitioners, midwives and other 206 
antenatal care providers have an important role in protecting their antenatal patients and 207 
newborn infants against influenza infection. Considering a provider recommendation for 208 
vaccination is the strongest predictor of antenatal vaccination [8] and the majority of women 209 
in our study stated they would have been vaccinated had a general practitioner or midwife 210 
recommended it to them, general practitioners and midwives could embrace a more active 211 
role in the promotion of antenatal immunisation services. Pregnant women view midwives as 212 
a trusted source of health information [23] and midwives, both publicly and privately practising, 213 
are ideally placed to provide antenatal immunisation information and recommendations during 214 
antenatal care visits and parent education sessions. In theory, based on our findings, if 100% 215 
of antenatal care providers recommended the vaccine to their pregnant patients, immunisation 216 
coverage rates up to 79% would be achievable. 217 
 218 
Other studies suggest that midwives may be less likely to recommend and administer 219 
influenza vaccine to pregnant patients as compared with other providers [24]. Our results 220 
showed that women who received most of their care at sites where midwives provide care 221 
(e.g., public hospital antenatal clinics) were less likely to receive a recommendation for TIV or 222 
to receive TIV during pregnancy. Although the majority of midwives agree that vaccinating 223 
pregnant women against seasonal influenza is important [25], researchers have found that 224 
midwives may not recommend influenza vaccine to their patients as often as other providers 225 
because they do not feel prepared for such conversations [25]. A recent study in the UK 226 
suggests that just 26% of midwives feel prepared to provide immunisation advice and only 227 
one-third of midwives are willing to immunise pregnant women [25]. Because midwives play 228 
an important role in promoting TIV to their patients and successful antenatal and post-natal 229 
immunisation programs rely on the support of midwives [26, 27], it is important to identify 230 
barriers in promoting and providing TIV during pregnancy experienced by midwives, 231 
particularly midwives practising in Australia. In Western Australia, influenza immunisation 232 
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education resources are available to healthcare professionals at no cost [28]; additional 233 
immunisation education needs of midwives should be identified in order to provide targeted 234 
immunisation education programs for midwives. 235 
 236 
Results from this survey can assist antenatal care providers, including general practitioners, 237 
obstetricians, and midwives, to effectively communicate with their pregnant patients for 238 
discussing antenatal immunisation. More than 90% of the vaccinated women in our survey 239 
reported being immunised to protect their baby. These results are consistent with those from 240 
other national and international research efforts [8, 11, 13] indicating this is an important 241 
message to convey to pregnant women when discussing immunisation. Unvaccinated women 242 
commonly cited concerns about the safety of the vaccine as a reason for remaining 243 
unvaccinated. Vaccine safety has been well demonstrated for both mothers and their infants 244 
in Australia and internationally [29-31]. Providers should discuss the demonstrated safety of 245 
influenza vaccination during pregnancy when recommending TIV to pregnant patients. The 246 
themes identified in this study could be used to develop effective communication materials 247 
summarising immunisation information for pregnant women. 248 
 249 
Our study has several limitations which should be considered. First, most of the data were 250 
self-reported and, as a result, are subject to reporting bias. Second, 15% of vaccinated women 251 
received their vaccination from a provider for whom we could not access the patient’s medical 252 
record (i.e. immunisations that were provided in a private workplace). It is therefore possible 253 
that a portion of these reported vaccination events were errors and these women were in fact 254 
unvaccinated; however, given that the proportion of vaccines reportedly administered by 255 
providers without access to medical records did not vary over time, it is unlikely that this would 256 
explain the trends we observed during the study period. Furthermore, 91% of self-reported 257 
vaccinations administered by a provider with immunisation records could be verified, indicating 258 
self-report is a valid measure of vaccination status. Finally, some sub-analyses, particularly 259 
analyses by primary antenatal care provider, relied on small sample sizes for some groups. 260 
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Additional research should further explore the association between models of antenatal care 261 
and recommendations for, and receipt of, TIV during pregnancy.  262 
 263 
Conclusion 264 
Influenza vaccination during pregnancy is standard of care in Australia [32] and research in 265 
many countries has shown that the recommendation of the antenatal care providers is an 266 
important factor in a woman’s decision to be vaccinated during pregnancy. Our results showed 267 
that only two of every five women in Western Australia received an influenza vaccine during 268 
their pregnancy in 2014. Significant improvement in antenatal influenza immunisation rates 269 
are needed to ensure pregnant women and their young infants are protected against seasonal 270 
influenza infection. We estimate that almost 80% coverage is achievable if all antenatal care 271 
providers recommended the vaccine to their pregnant patients. With the recent introduction of 272 
pertussis vaccination to antenatal vaccination programs in Australia [33], it will become 273 
increasingly important for all antenatal care providers to actively promote antenatal 274 
vaccination. Consistent recommendations from all antenatal care providers, including 275 
midwives, and discussion of the safety and potential benefits are critical to improving influenza 276 
vaccine coverage in pregnant women.  277 
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Figure 1. Verification of influenza vaccination records in pregnant women – Western 
Australia, 2012-14. 
 
*65 vaccinations were administered by an immunisation provider who maintained vaccination 290 
records, could confirm the woman was a patient, but could not locate a vaccination record for 291 
the woman. 292 
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Table 1. Percentage of women recommended and/or receiving a seasonal trivalent influenza vaccine during pregnancy – Western Australia, 
2012-14. 
 Total Recommended vaccinea Received vaccineb 
 n (weighted %) n (weighted %) AORc (95% CI) n (weighted %) AOR* (95% CI) 
OVERALL 1,888 (100) 1,062 (57.2) --- 686 (35.3) --- 
MATERNAL CHARACTERISTICS      
By age group      
    18-24y 229 (17.2) 118 (52.0) 0.83 (0.57-1.20) 67 (27.1) 0.76 (0.52-1.10) 
    25-29y 499 (29.2) 270 (56.8) 0.98 (0.75-1.30) 166 (34.2) 0.96 (0.73-1.27) 
    30-34y 677 (33.1) 393 (59.2) 1.04 (0.81-1.33) 266 (38.7) 1.09 (0.85-1.39) 
    35-45y 483 (20.5) 281 (58.9) Ref 187 (38.1) Ref 
By health status      
    ≥1 medical conditiond 244 (13.2) 156 (63.5) 1.39 (1.01-1.91)* 95 (37.5) 1.16 (0.86-1.55) 
   No medical conditions 1,644 (86.8) 906 (56.2) Ref 591 (34.9) Ref 
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By educational attainment      
    ≤High school 563 (32.2) 306 (56.2) 1.11 (0.82-1.52) 180 (31.1) 0.72 (0.53-0.98)* 
    TAFE/some university 986 (51.6) 560 (57.5) 1.06 (0.81-1.38) 356 (35.3) 0.77 (0.59-1.00) 
    ≥University graduate 339 (16.2) 196 (58.0) Ref 150 (43.6) Ref 
By socioeconomic status      
    Tertile 1 (Most disadvantaged) 504 (27.9) 264 (55.0) 1.01 (0.76-1.34) 182 (35.3) 1.16 (0.88-1.52) 
    Tertile 2 586 (31.3) 325 (56.0) 0.99 (0.76-1.34) 200 (33.4) 1.00 (0.78-1.28) 
    Tertile 3 (Least disadvantaged) 798 (40.8) 473 (59.6) Ref 304 (36.7) Ref 
By residence      
    Non-metropolitan 498 (27.0) 244 (51.1) 0.75 (0.58-0.98)* 159 (32.4) 0.90 (0.69-1.17) 
    Metropolitan 1,390 (72.9) 818 (59.5) Ref 527 (36.3) Ref 
ANTENATAL CARE 
CHARACTERISTICS 
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aRecommended vaccine was defined as women who self-reported a healthcare provider recommended influenza vaccination during their most recent pregnancy. 
bReceived vaccine was defined as women who self-reported receiving an influenza vaccine during their most recent pregnancy and the vaccination was either verified by their immunisation provider 
or was administered by a provider with no immunisation records. 
cAOR, odds ratio adjusted for maternal age group, pre-existing medical conditions, socioeconomic status, educational attainment, residence and antenatal care provider. 
dPre-existing medical conditions included asthma, heart disease, or chronic lung disease. 
 
Location of majority of antenatal care      
    Private obstetrician 702 (34.9) 441 (62.8) Ref 314 (43.6) Ref 
    General practitioner 379 (20.0) 187 (51.7) 0.73 (0.54-0.99)* 123 (32.7) 0.70 (0.52-0.94)* 
    Public antenatal hospital 786 (43.7) 426 (55.5) 0.76 (0.60-0.95)* 244 (30.1) 0.60 (0.48-0.76)* 
    Private practice midwife 21 (1.2) 8 (42.3) 0.49 (0.20-1.24) 5 (24.3) 0.50 (0.17-1.43) 
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Figure 2. Provider recommendations for influenza vaccination during pregnancy – 2012-14, 
Western Australia 
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Table 2. Reasons for influenza vaccination or non-vaccination during pregnancy – 2012-14, Western Australia. 
 2012  2013 2014 
p-valuea  n       (weighted %) n         (weighted %) n          (weighted %) 
Reasons for vaccination        
    To protect the baby 65 74.7 (64.9-84.5) 250 91.0 (87.7-94.2) 289 92.8 (89.9-95.7) 0.002 
    A HCPb recommended it 70 78.8 (69.8-87.7) 221 80.2 (75.4-84.9) 262 85.5 (81.5-89.4) 0.06 
         General practitioner recommended it 57 65.1 (54.8-75.4) 150 55.7 (49.7-61.8) 172 57.6 (51.8-63.4) 0.86 
         Obstetrician recommended it 50 56.1 (45.3-66.9) 137 48.3 (42.3-54.4) 146 47.7 (41.8-53.6) 0.26 
         Midwife recommended it 26 29.9 (19.9-39.9) 100 37.1 (31.2-43.0) 112 35.3 (29.8-40.9) 0.84 
    Worried about influenza infection 57 63.9 (53.4-74.3) 163 57.8 (51.8-63.8) 179 56.5 (50.7-62.3) 0.07 
    Normally get seasonal vaccine 37 40.7 (30.1-51.3) 99 35.2 (29.4-41.0) 156  47.3 (41.5-53.1) 0.27 
    Have an at-risk medical condition 12 13.2 (6.0-20.3) 18 5.8 (3.1-8.5) 31 9.9 (6.5-13.3) 0.92 
    Offered at workplace 9 9.1 (3.2-15.0) 12 4.2 (1.8-6.6) 21 6.0 (2.5-8.5) 0.99 
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Reasons for non-vaccination          
    Don’t normally get a flu vaccine 188 67.0 (61.4-72.6) 298 68.1 (63.6-72.6) 167 39.7 (34.5-45.0) <0.001 
    Concerned about harm to baby 139 49.6 (43.6-55.6) 191 41.9 (37.1-46.6) 175 42.9 (37.4-48.4) 0.05 
    Was not recommended by any HCP 132 47.9 (41.9-53.9) 157 36.7 (32.0-41.4) 186 48.5 (42.8-54.1) 0.73 
    Worried about side effects 142 46.8 (41.0-52.6) 194 43.1 (38.3-47.8) 175 43.3 (37.8-48.9) 0.22 
    Did not think was necessary 29 10.5 (6.8-14.2) 32 7.1 (4.7-9.5) 7 1.5 (0.4-2.6) <0.001 
    Advised against vaccination by provider 14 5.4 (2.6-8.1) 20 4.8 (2.7-6.9) 14 4.9 (1.4-8.4) 0.74 
    Accessibility of vaccinec 12 3.8 (1.7-6.0) 13 3.0 (1.3-4.6) 11 2.4 (0.9-3.9) 0.35 
ap-value of logistic regression assessing trend and adjusting for socioeconomic status, educational attainment and residence. 
b†HCP, healthcare provider. 
aAccessibility of vaccine included issues with accessing a healthcare provider to administer the vaccine. 
 
 
